Up to now the most complex meta-analysis of 205,523 male subjects and 7053 PC cases demonstrate no association between PC risk and insulin use, in comparison to other antidiabetic drugs (RR = 0.89, 95% CI: 0.72–1.09). The gene discussed is INS; the disease is pachyonychia congenita.